NCT04796545View on ClinicalTrials.gov

Post-market Clinical Investigation of the SING IMT System, Model NG SI IMT 3X in Patients With End-stage Age-related Macular Degeneration

NARecruitingINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

September 13, 2022

Primary Completion Date

February 28, 2027

Study Completion Date

December 31, 2028

Conditions
AMDAge-Related Macular Degeneration
Interventions
DEVICE

SING IMT(TM) System, model NG SI IMT 3X

The SING IMT 3X implant is a visual prosthetic implantable device, which, when combined with the optics of the cornea, constitutes a telephoto system for improvement of visual acuity in patients with bilateral, end-stage age-related macular degeneration.

Trial Locations (8)

Unknown

TERMINATED

Augenklinik Städtisches Klinikum Karlsruhe, Karlsruhe

ACTIVE_NOT_RECRUITING

Universitätsklinikum Münster Klinik für Augenheilkunde, Münster

RECRUITING

Mater Misericordiae University Hospital, Dublin

NOT_YET_RECRUITING

Università degli Studi di Napoli Federico II, Napoli

RECRUITING

Fondazione Policlinico Universitario Agostino Gemelli, Roma

RECRUITING

VISSUM, Alicante

RECRUITING

Institut OMIQ, Barcelona

NOT_YET_RECRUITING

Royal Victoria Hospital Belfast Health & Social Care Trust, Belfast

All Listed Sponsors
lead

VisionCare, Inc.

INDUSTRY